Obesity drugs
Zealand Pharma’s stock swings show weight-loss drug market’s new test
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment
Copenhagen news
Read verified news on BetaVoices covering Copenhagen, with reporting, context, and related developments.
Copenhagen
Clear filters